Newsroom | 40776 results

Sorted by: Latest

Medical Devices
-

Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 38 abstracts, as well as one oral presentation in partnership with Pfizer, showcasing advances in methylation-based tumor classification and liquid biopsy technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois taking place May 29 – June 2, 2026. Key data that will be prese...
-

ACP Partners with Heritage Imaging as its Next Platform

CLEVELAND & DALLAS--(BUSINESS WIRE)--Align Capital Partners (“ACP”) is pleased to announce the acquisition of Heritage Imaging (“Heritage” or the “Company”), a provider of mobile diagnostic imaging services to hospitals and healthcare facilities. Heritage is led by Chief Executive Officer Dr. Steve Coppess, who will continue to lead the Company post-transaction alongside the current management team. Founded in 1989, Heritage delivers advanced diagnostic imaging solutions to hospitals and other...
-

European Radiosurgery Center Munich Surpasses 1,000 Patients Treated with ZAP-X Gyroscopic Radiosurgery

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the European Radiosurgery Center Munich (ERCM) has treated more than 1,000 patients with the ZAP-X® Gyroscopic Radiosurgery® platform. The milestone reflects ERCM’s continued leadership in stereotactic radiosurgery (SRS), a completely non-invasive and painless procedure used to treat many primary and metastatic brain tumors, as well as select disorders of...
-

Aptar Pharma Announces New Patent Applications and Preclinical Data Supporting Investigation of Intranasal and Pulmonary GLP-1 Delivery

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma announces patent applications and preclinical data supporting investigational intranasal and pulmonary GLP-1 delivery....
-

VB Spine suscribe un acuerdo marco con Apolo Medica

NUEVA YORK--(BUSINESS WIRE)--VB Spine LLC ("VB Spine"), una empresa familiar especializada en la salud de la columna vertebral con presencia internacional, ha anunciado hoy que ha firmado un acuerdo marco de servicios con Apolo Medica para iniciar la distribución de los productos de VB Spine en México. Este anuncio llega tras la expansión reciente de VB Spine a los Países Bajos, Luxemburgo, Bélgica, Australia y Nueva Zelanda. "Nos llena de entusiasmo poder ampliar aún más el alcance de VB Spine...
-

ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation

DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation...
-

Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.83 billion for the second quarter ended April 30, 2026, representing growth of 10.0% reported and up 6.3% core(1) compared with the second quarter of 2025. Second-quarter GAAP net income was $339 million, or $1.20 per share. This compares with $215 million, or $0.75 per share, in the second quarter of 2025. Non-GAAP net income(3) was $423 million, or $1.49 per share, during the quarter, compar...
-

Insulet to Participate in William Blair 46th Annual Growth Stock Conference

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the William Blair 46th Annual Growth Stock Conference in Chicago on Wednesday, June 3, 2026 at 2:00 p.m. (Central Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insul...
-

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL. Pulse Biosciences’ Management is scheduled to present on Wednesday, June 10, at 10:00 am ET. A live and recorded webcast of the fireside chat will be available on the “Events Calendar and Presentat...
-

Alesis LLC Expands to the Pacific Northwest With Dr. Lyly Fisher — First Seattle-Area Provider of Alesis OSA1™

COCOA BEACH, Fla. & SEATTLE--(BUSINESS WIRE)--Alesis LLC, the U.S. distributor of the Alesis OSA1™ medical device, today announced a joint venture partnership with Dr. Lyly Fisher, DDS, Diplomate, ABDSM, ASBA -- a dual board-certified sleep dentist with offices in Seattle and Renton, Washington. Dr. Fisher is the first sleep dentist in the Seattle area to offer Alesis OSA1, a breakthrough non-surgical treatment for patients with obstructive sleep apnea (OSA) who cannot tolerate CPAP therapy. Th...